Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 6Other hematologic neoplasm 3Gastrointestinal 3Thoracic 2Lymphoid 2Gynecologic 2Classical hematology 2Plasma cell 1Other neoplasm 1Myeloid 1Genitourinary 1Dermatologic 1

Conditions

Precancerous Conditions 32Neoplasms, Plasma Cell 10Multiple Myeloma 10Lymphoma 10Leukemia 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Monoclonal Gammopathy of Undetermined Significance 8Lymphoma, T-Cell, Cutaneous 8Lymphoma, Non-Hodgkin 8Lymphoma, Mantle-Cell 8Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, Large-Cell, Anaplastic 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 8Leukemia, Lymphocytic, Chronic, B-Cell 8Immunoglobulin Light-chain Amyloidosis 8Immunoblastic Lymphadenopathy 8Hodgkin Disease 8Waldenstrom Macroglobulinemia 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myeloproliferative Disorders 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Prolymphocytic 7Leukemia, Large Granular Lymphocytic 7Leukemia, Hairy Cell 7Keratosis, Actinic 7Burkitt Lymphoma 7Thrombocythemia, Essential 6Sezary Syndrome 6Primary Myelofibrosis 6

Interventions

Epoetin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Drug-Related Side Effects and Adverse Reactions × Other neoplasm × Clear all
NCT00003600 2016-07-13

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
344 enrolled
BreastClassical hematologyLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cellThoracic

Anemia, Breast Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Precancerous Conditions, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡